principle of specification | rule of specification

rule of specification [ principle of specification ]

A rare chromosomal anomaly syndrome with a highly variable phenotype ranging from normal (in the majority of cases) to a mild, subtle phenotype. Principle characteristics are spinal abnormalities (stenosis, vertebral fusion, and kyphosis), hypotonia,

principle of specificity

equal pay for equal work principle | equal pay principle | principle of equal pay | principle of equal pay for equal work | principle of equal pay for equal work or work of equal value | principle of equal pay for male and female workers for equal work | principle of equal pay for male and female workers for equal work or work of equal value | the principle that men and women should receive equal pay for equal work

Heisenberg indeterminacy principle | Heisenberg uncertainty principle | indeterminacy principle | uncertainty principle | principle of indeterminacy | principle of uncertainty | Heisenberg principle

provenance [ respect des fonds | Principle of Sanctity of the Original Order | Registry principle | principle of provenance | principle of respect of funds | principle of respect of archival structure ]

Bellman principle [ Bellman's principle | principle of optimality | optimality principle ]

A rare chromosomal anomaly syndrome with a highly variable phenotype. Principle characteristics are a neonatal mewing cry, severe developmental delay and intellectual disability, short stature, hypotonia, dysmorphic features (including microcephaly,

A rare chromosomal anomaly syndrome with a highly variable phenotype. Principle characteristics are prenatal and postnatal growth delay, mild to severe intellectual disability, hemiatrophy, webbed neck, ocular and cutaneous pigmentary anomalies, cran

specific to the EU: the Court of Justice identified the principles specific to the EU even if the source of their inspiration was from a national legislation.

4. Requires the Member States, the Commission and the international community to coordinate and strengthen medical research and the production of effective medicines and vaccines against Ebola and other emerging diseases that are otherwise neglected by the pharmaceutical commercial sector, taking care to ensure that these trials take place under ethical conditions whereby patients give informed consent prior to taking part, and there is transparency concerning clinical data stemming from this research and genuine access, where possible free of charge, to these vaccines and treatment for the populations targeted (skilled staff and suitable facilities for administration of treatment, prices not to exceed the real cost of production); regrets ...[+++] the fact, however, that grant agreements for the Ebola+ projects will be signed after the release of the IMI funds and not beforehand, and expects pharmaceutical companies involved to adhere to and respect corporate social responsibility principles, specifically by means of affordability of the innovative vaccine treatment;

(14) This Directive respects fundamental rights and observes the principles specifically recognised in particular by the Charter of Fundamental Rights of the European Union.

A key principle specific to the governance of the Structural Funds is the partnership principle, which has made for more transparent, more open and more integrated governance of cohesion policy. However, it is not yet applied anything like as widely as it should be.